Page last updated: 2024-09-03

astragaloside a and natriuretic peptide, brain

astragaloside a has been researched along with natriuretic peptide, brain in 4 studies

Compound Research Comparison

Studies
(astragaloside a)
Trials
(astragaloside a)
Recent Studies (post-2010)
(astragaloside a)
Studies
(natriuretic peptide, brain)
Trials
(natriuretic peptide, brain)
Recent Studies (post-2010) (natriuretic peptide, brain)
675557316,3171,8678,887

Protein Interaction Comparison

ProteinTaxonomyastragaloside a (IC50)natriuretic peptide, brain (IC50)
Atrial natriuretic peptide receptor 1Homo sapiens (human)0.006

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Liang, L; Lu, M; Maslov, LN; Wang, H; Wang, J; Yang, J; Zhang, J1
Lu, M; Luan, A; Tang, F; Wang, H; Yang, J; Yang, Y; Zhang, J; Zhang, S1
Li, J; Liu, H; Ren, X; Shao, J; Wang, X; Xu, L; Xu, M; Zhang, W1
Cui, XY; Li, D; Li, XX; Li, Y; Lin, Q; Liu, J; Lu, JJ; Wu, Y; Zhou, K1

Reviews

1 review(s) available for astragaloside a and natriuretic peptide, brain

ArticleYear
Astragaloside IV for Heart Failure: Preclinical Evidence and Possible Mechanisms, A Systematic Review and Meta-Analysis.
    Chinese journal of integrative medicine, 2023, Volume: 29, Issue:7

    Topics: Animals; Heart Failure; Mice; Natriuretic Peptide, Brain; Rats; Stroke Volume; Ventricular Function, Left

2023

Other Studies

3 other study(ies) available for astragaloside a and natriuretic peptide, brain

ArticleYear
Astragaloside IV protects against cardiac hypertrophy via inhibiting the Ca2+/CaN signaling pathway.
    Planta medica, 2014, Volume: 80, Issue:1

    Topics: Animals; Atrial Natriuretic Factor; Calcineurin; Calcium Signaling; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Drugs, Chinese Herbal; Lipopolysaccharides; Myocytes, Cardiac; Natriuretic Peptide, Brain; NFATC Transcription Factors; Rats; Saponins; Signal Transduction; Triterpenes

2014
Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
    PloS one, 2015, Volume: 10, Issue:3

    Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Down-Regulation; Energy Metabolism; Gene Knockdown Techniques; Heart Ventricles; Hemodynamics; Isoproterenol; Male; Mitochondria; Myocytes, Cardiac; Natriuretic Peptide, Brain; NF-kappa B; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Sprague-Dawley; RNA, Messenger; RNA, Small Interfering; Saponins; Signal Transduction; Transcription Factor RelA; Transcription Factors; Triterpenes

2015
Astragaloside IV Reduces OxLDL-Induced BNP Overexpression by Regulating HDAC.
    Journal of healthcare engineering, 2021, Volume: 2021

    Topics: Animals; Histone Deacetylases; Lipoproteins, LDL; Mice; Natriuretic Peptide, Brain; Quality of Life; Saponins; Triterpenes

2021